<ѻý>Adjuvant Pembrolizumab Boosts DFS in High-Risk Muscle Invasive Urothelial Cancerѻý> Benefit more than double with the immune checkpoint inhibitor compared with observation Jan 28, 2024
<ѻý>Cancer After Weight Loss; How Older Adults Use the Healthcare Systemѻý> Also in TTHealthWatch: PFAS guidelines for clinicians Jan 27, 2024 podcast
<ѻý>When a Revolutionary Cancer Treatment Causes Cancerѻý> The potential benefits of CAR T-cell therapies still far outweigh the risks Jan 27, 2024
<ѻý>No Cervical Cancer After HPV Vax; Brain Tumor Blood Test; Weight Loss and Cancerѻý> News, features, and commentary about cancer-related issues Jan 26, 2024
<ѻý>Native Hawaiian Physician-Scientist Kekoa Taparra Is Making Wavesѻý> One of the first Native Hawaiians with an MD, PhD is tackling Pacific Islander health disparities Jan 23, 2024
<ѻý>New FDA Boxed Warning; College Shaken by Suicides; More Get Flu Shot Than COVID Vaxѻý> Health news and commentary from around the Web gathered by ѻý staff Jan 23, 2024
<ѻý>Neoadjuvant PD-1 Blockade Boosts pCR Rates in Early Esophageal Cancerѻý> But will the benefit extend to event-free and overall survival? Jan 22, 2024
<ѻý>New Standard for Unresectable Hepatocellular Carcinoma?ѻý> Adding durvalumab and bevacizumab to transarterial chemoembolization almost doubles PFS Jan 21, 2024
<ѻý>HAIP Chemo Offers OS Advantage in Advanced Intrahepatic Cholangiocarcinomaѻý> One in three trial patients still alive at 3 years after hepatic arterial infusion pump treatment Jan 20, 2024
<ѻý>Radioligand Gets Big Win in High-Grade GEP Neuroendocrine Tumorsѻý> Lutetium dotatate reduces PFS risk by 72% in randomized trial Jan 20, 2024
<ѻý>Adding Immunotherapy, Anti-TIGIT in First Line Boosts OS in Esophageal Cancerѻý> But how much did investigational tiragolumab contribute to efficacy? Jan 19, 2024
<ѻý>Two Million Cancers; Casgevy OK'd for Thalassemia; Rectal Exams and Prostate Cancerѻý> News, features, and commentary about cancer-related issues Jan 19, 2024
<ѻý>Long-Term Data Affirm First-Line Immunotherapy for Advanced Esophageal Cancerѻý> Three times as many patients alive at 5 years with chemo plus pembrolizumab Jan 19, 2024
<ѻý>Certain Cancer Survivors More Likely to Have Substance Use Disorderѻý> Prevalence particularly high in those recently diagnosed with head and neck and cervical cancers Jan 17, 2024
<ѻý>Cost of Genomic Testing on the Minds of Many Oncologistsѻý> Insurance coverage, patient out-of-pocket costs key considerations for 80% of survey respondents Jan 16, 2024
<ѻý>Go Vegetarian to Avoid COVID? Making Dialysis Centers Work Betterѻý> Also in TTHealthWatch: diagnostic errors among hospitalized patients Jan 13, 2024 podcast
<ѻý>Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCAѻý> News, features, and commentary about cancer-related issues Jan 12, 2024
<ѻý>COVID Vax and Blood Clots; Cancer Rise in Young Adults; Corpse-Abuse Charge Droppedѻý> Health news and commentary from around the Web gathered by ѻý staff Jan 12, 2024
<ѻý>Carvedilol No Help in Preventing Heart Failure in Childhood Cancer Survivorsѻý> While safe, the results do not support use of the drug in anthracycline-exposed survivors Jan 10, 2024
<ѻý>Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRCѻý> T-cell response linked to 86% reduced risk of relapse, death Jan 09, 2024
<ѻý>Retinal Tumor Risk Incidentally Detected at 29 Weeks' Gestationѻý> Finding poses clinical and ethical dilemma for parents and clinicians Jan 08, 2024
<ѻý>Collaboration Between Local Oncologists and Academia Is Crucialѻý> Greater partnerships can optimize cancer care outcomes Jan 06, 2024
<ѻý>Language Minimizing Adverse Events; HPV and Thyroid Cancer; Ultrasound Brasѻý> News, features, and commentary about cancer-related issues Jan 05, 2024
<ѻý>Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonistsѻý> Researchers looked at 7-year patient data Jan 04, 2024
<ѻý>Futile Immunotherapy for Cancer Grows More Commonѻý> Occurs most often at non-academic and low-volume centers Jan 04, 2024
<ѻý>Lessons From the Chemotherapy Shortages: Invest in Genericsѻý> We need more sustainable solutions to ensure treatment access Dec 31, 2023
<ѻý>Cancer Patients Face Frightening Delays in Treatment Approvalsѻý> "For them to take weeks -- up to months -- to provide an authorization is ridiculous" Dec 30, 2023
<ѻý>Another CAR-T Warning; 'Sweet' Cancer Test; 'Molecular Jackhammer' Blows Up Cancerѻý> News, features, and commentary about cancer-related issues Dec 28, 2023
<ѻý>Mind of the 'Maestro': Inside the Head of Leonard Bernsteinѻý> Psychiatrist and concert pianist Richard Kogan, MD, on the great composer's complex inner life Dec 27, 2023
<ѻý>Significant Left Nasal Obstruction Finally Diagnosed After 2 Yearsѻý> Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man Dec 26, 2023
<ѻý>Mammo Responsibility Ups Screening; Opioids for Cancer Pain? Ignored Signs of CRCѻý> News, features, and commentary about cancer-related issues Dec 21, 2023
<ѻý>Homelessness Tied to Worse Cancer Outcomes Among Veteransѻý> However, all-cause mortality rates in lung, colon cancer lower versus other healthcare settings Dec 21, 2023
<ѻý>Psilocybin May Help Ease Depression in Cancer Patientsѻý> In small trial, half had early remission of depressive symptoms after psilocybin-assisted therapy Dec 18, 2023
<ѻý>National Database Study Finds Higher Risk for Barrett’s Esophagus in IBDѻý> But no greater chance of BE-tied malignancy for these patients Dec 16, 2023
<ѻý>FDA Approves New First-Line Standard of Care in Bladder Cancerѻý> Enfortumab vedotin plus pembrolizumab doubled survival as compared with chemotherapy Dec 15, 2023
<ѻý>Andre Braugher's Cancer Dx; Malignancies Rising in Younger Adults; Negative Trialsѻý> News, features, and commentary about cancer-related issues Dec 14, 2023
<ѻý>FDA OKs Maintenance Option for High-Risk Neuroblastomaѻý> Eflornithine approved to reduce relapse risk in both kids and adults Dec 14, 2023
<ѻý>'Half-Matched' BMTs Effective in Severe Sickle Cell Diseaseѻý> High survival rates observed in patients not normally suitable for transplant Dec 13, 2023
<ѻý>Lenvatinib-Pembrolizumab Combo Misses Goal in First-Line HCC Trialѻý> Numerical advantages in OS, PFS fall short of statistical significance Dec 13, 2023
<ѻý>EUS-Guided Gastroenterostomy Better Option for Cancer-Related Duodenal Blockagesѻý> However, technique and technology are not widespread Dec 08, 2023